These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3089139)

  • 1. Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolates.
    Livermore DM; Jones CS
    Antimicrob Agents Chemother; 1986 Jan; 29(1):99-103. PubMed ID: 3089139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
    Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
    J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.
    Danel F; Hall LM; Gur D; Akalin HE; Livermore DM
    J Antimicrob Chemother; 1995 Feb; 35(2):281-94. PubMed ID: 7759392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
    Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
    Tausk F; Evans ME; Patterson LS; Federspiel CF; Stratton CW
    Antimicrob Agents Chemother; 1985 Jul; 28(1):41-5. PubMed ID: 3929679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa.
    Ben-Mahrez K; Rejiba S; Belhadj C; Belhadj O
    Res Microbiol; 1999; 150(6):403-6. PubMed ID: 10466408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New plasmid-mediated oxacillin-hydrolyzing beta-lactamase in Pseudomonas aeruginosa.
    Philippon AM; Paul GC; Jacoby GA
    J Antimicrob Chemother; 1986 Apr; 17(4):415-22. PubMed ID: 3086272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Nordmann P; Ronco E; Naas T; Duport C; Michel-Briand Y; Labia R
    Antimicrob Agents Chemother; 1993 May; 37(5):962-9. PubMed ID: 8517722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates.
    Danel F; Hall LM; Gur D; Livermore DM
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3117-22. PubMed ID: 9835501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
    Hall LM; Livermore DM; Gur D; Akova M; Akalin HE
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa.
    Krasauskas R; Labeikytė D; Markuckas A; Povilonis J; Armalytė J; Plančiūnienė R; Kavaliauskas P; Sužiedėlienė E
    Ann Clin Microbiol Antimicrob; 2015 Nov; 14():52. PubMed ID: 26611758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of strains producing plasmid determined beta-lactamases among carbenicillin resistant Pseudomonas aeruginosa.
    Tirado M; Roy C; Segura C; Reig R; Hermida M; Foz A
    J Antimicrob Chemother; 1986 Oct; 18(4):453-8. PubMed ID: 3095304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
    Michel-Briand Y; Nicolas T; Godard C; Plesiat P
    Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey.
    Bonfiglio G; Laksai Y; Franchino L; Amicosante G; Nicoletti G
    J Antimicrob Chemother; 1998 Dec; 42(6):697-702. PubMed ID: 10052891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.